Ofloxacin Unimed Pharma (Ofloxacin)

Ofloxacin ophthalmic solution is indicated for bacterial infections of the eye and related structures.

• Bacterial conjunctivitis: reduces bacterial load and resolves infection.
• Bacterial keratitis: eradicates causative organisms and promotes corneal healing.
• Other susceptible ocular infections: treats infection caused by susceptible strains, improving visual outcomes.

• Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents supercoiling and separation of DNA strands, leading to bacterial cell death. The drug exhibits bactericidal activity against a broad range of Gram‑negative and Gram‑positive ocular pathogens.

Topical ofloxacin may cause local and systemic adverse reactions, although systemic exposure is limited.

Common Side Effects

• Eye irritation: mild burning or stinging upon instillation.
• Redness: conjunctival hyperemia.
• Itching: mild pruritus.
• Foreign body sensation: feeling of grit.
• Blurred vision: transient visual disturbance.
• Dryness: ocular surface dryness.

Serious or Rare Side Effects

• Allergic reaction: swelling, rash, or anaphylaxis.
• Corneal ulceration: worsening of corneal lesions.
• Severe ocular inflammation: uveitis or keratitis.
• Vision loss: rare but possible.
• Contact lens intolerance: inability to wear lenses.
• Systemic hypersensitivity: fever, chills.

Before using Ofloxacin ophthalmic solution, consider the following precautions.

• Allergy assessment: verify no known hypersensitivity to fluoroquinolones.
• Contact lens use: avoid wearing lenses until treatment is completed.
• Corneal integrity: do not use on a perforated cornea.
• Pregnancy and lactation: use only if clearly needed; data are limited.
• Concurrent ocular medications: avoid mixing with other eye drops unless directed.
• Store at ambient temperature: keep in the original container, protect from light and moisture.

Ofloxacin ophthalmic solution can interact with other medicines; review the following.

Major Interactions (Avoid)

• Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity.
• Anticholinergic eye drops: may reduce ocular absorption.
• NSAID eye drops: potential for additive irritation.
• Live vaccines: theoretical risk of reduced efficacy.
• CYP450 inhibitors: may affect systemic metabolism, though exposure is minimal.

Moderate Interactions (Monitor Closely)

• Other topical antibiotics: may cause antagonism.
• Corticosteroid eye drops: may mask infection signs.
• Herbal supplements containing quinine: possible additive QT effects.
• Diuretics: monitor for electrolyte changes.
• Antacids: may alter ocular pH and affect drug stability.